Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis

被引:0
作者
Lakshmi Narasimha Thota
Thiruvelselvan Ponnusamy
Xinjie Lu
Lakshmi Mundkur
机构
[1] Thrombosis Research Institute,Research Scholar, Manipal University
[2] Thrombosis Research Institute,Molecular Immunology unit
[3] Thrombosis Research Institute,Molecular Immunology unit
[4] Narayana Hrudayalaya,undefined
来源
Cardiovascular Drugs and Therapy | 2019年 / 33卷
关键词
Atherosclerosis; Immune modulation; Regulatory T cells; Inflammation; Autoimmunity; Protective antibodies; Safety studies;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:385 / 398
页数:13
相关论文
共 254 条
[1]  
Fredrikson GN(2003)Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences Arterioscler Thromb Vasc Biol 23 879-884
[2]  
Soderberg I(2003)Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL Nat Med 9 736-743
[3]  
Lindholm M(2012)Effects of nasal immunization of multi-target preventive vaccines on atherosclerosis Vaccine. 30 1029-1037
[4]  
Dimayuga P(2004)Autoimmune and inflammatory mechanisms in atherosclerosis Annu Rev Immunol 22 361-403
[5]  
Chyu KY(2008)Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med 263 464-478
[6]  
Shah PK(2016)Innate sensing of oxidation-specific epitopes in health and disease Nat Rev Immunol 16 485-497
[7]  
Binder CJ(2011)Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity Circ Res 108 235-248
[8]  
Horkko S(2003)Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 330-336
[9]  
Dewan A(2013)Immune effector mechanisms implicated in atherosclerosis: from mice to humans Immunity. 38 1092-1104
[10]  
Chang MK(2009)Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease J Intern Med 266 221-231